02:21:45 EDT Wed 01 May 2024
Enter Symbol
or Name
USA
CA



Zentek Ltd
Symbol ZEN
Shares Issued 100,988,919
Close 2023-10-06 C$ 1.67
Market Cap C$ 168,651,495
Recent Sedar Documents

Zentek shareholders approve all matters at ASM

2023-10-10 11:54 ET - News Release

Mr. Francis Dube reports

ZENTEK ANNOUNCES VOTING RESULTS OF ANNUAL AND SPECIAL MEETING

Zentek Ltd. has released the voting results from the annual and special meeting of the company's shareholders held on Oct. 5, 2023. At the meeting, shareholders voted in favour of all resolutions brought before them. Details of all resolutions that were voted on are set out in the management information circular dated Aug. 28, 2023. The management information circular is available on SEDAR+.

Election of directors

All of the director nominees listed in the management information circular were elected as directors of the company. Results of the vote are provided in an attached table.

Other items of business

In addition, at the meeting, shareholders approved the appointment of the company's auditor, BDO Canada LLP, the adoption of an omnibus long-term incentive plan and a change to company's registered address. The results of the votes are provided in an attached table.

About Zentek Ltd.

Zentek is an ISO 13485:2016-certified intellectual property technology company focused on the research, development and commercialization of novel products seeking to give the company's commercial partners a competitive advantage by making their products better, safer and greener.

Zentek's patented technology platform, ZenGuard, is shown to have 99-per-cent anti-microbial activity and to significantly increase the bacterial and viral filtration efficiency of both surgical masks and HVAC (heating, ventilation and air conditioning) systems. Zentek's ZenGuard production facility is in Guelph, Ont. Zentek's patent-pending ZenArmor technology platform is focused on corrosion protection applications.

Zentek also has a global exclusive licence to the aptamer-based platform technology developed by McMaster University, which is being jointly developed by Zentek and McMaster for both the diagnostic and therapeutic markets.

We seek Safe Harbor.

© 2024 Canjex Publishing Ltd. All rights reserved.